Sensitivity of ASPRV1 towards protease inhibitors may also contribute to the better understanding of enzyme regulation in the treatment of skin disorders and chronic inflammatory autoimmune diseases such as MS and encephalomyelitis. This evidence concerns the gene ASPRV1 and encephalomyelitis.